Remarkable regression of inoperable pancreatic grade 3 neuroendocrine neoplasm after radioligand therapy with [177Lu]Lu-DOTATATE and [90Y]Y‑DOTATATE.
Autor: | Durma AD; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine – National Research Institute, Warsaw, Poland. adurma@wim.mil.pl, Saracyn M; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine – National Research Institute, Warsaw, Poland, Kołodziej M; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine – National Research Institute, Warsaw, Poland, Jóźwik-Plebanek K; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine – National Research Institute, Warsaw, Poland, Kamiński G; Department of Endocrinology and Radioisotope Therapy, Military Institute of Medicine – National Research Institute, Warsaw, Poland |
---|---|
Jazyk: | angličtina |
Zdroj: | Polish archives of internal medicine [Pol Arch Intern Med] 2023 Nov 29; Vol. 133 (11). Date of Electronic Publication: 2023 Oct 02. |
DOI: | 10.20452/pamw.16576 |
Databáze: | MEDLINE |
Externí odkaz: |
načítá se...